Answers are grounded in this paper and cite their sources.
To explore hypotheses for age-related changes in the incidence of Campylobacter infections in England and Wales during 1990-2007, we analyzed electronic laboratory data.Disease incidence reduced among children, and the greatest increase in risk was among those >60 years of age.Risk factors for campylobacteriosis in the elderly population should be identifi ed.C ampylobacter infection remains a major public health problem worldwide.The infection is unpleasant, although generally self-limiting, and most patients experience acute enteritis for 7 to 10 days (1).Approximately one tenth of patients with laboratory-confi rmed cases require hospital treatment as a result of their illness (2), and a range of gastrointestinal, arthritic, and neurologic sequelae add to disease effects (3).Although food is likely the main source of transmission to humans, most human infections cannot be explained by recognized risk factors.In the late 1970s, when the role of Campylobacter spp. in human gastrointestinal disease had been newly appreciated, the number of laboratory-confi rmed infections in England and Wales began to rise; 8,956 cases were reported in 1980 and 33,234 in 1989 (Health Protection Agency, unpub.data).This increase was largely artifactual, refl ecting increased scientifi c interest in, and testing for, Campylobacter spp.and improvements in media and methods for isolating them (4,5).The incidence continued to rise throughout the 1990s and peaked in 2000 at 58,236 cases.The reasons for this increase are unknown; further methodologic improvements or increased surveillance activity in that decade cannot fully explain it.Incidence rapidly decreased between 2000 and 2004 (from 57,674 to 44,294 cases; 24% decrease; Health Protection Agency, unpub.data), after which incidence increased for 3 consecutive years; provisional total was 51,758 cases in 2007 (Health Protection Agency, unpub.data).The reasons for these recent changes in incidence are again unknown.To explore hypotheses for changes in incidence related to age, we analyzed electronic laboratory data for Campylobacter infections reported in England and Wales from 1990 through 2007. The StudyData on all Campylobacter isolates obtained from fecal or lower gastrointestinal tract samples, reported in England and Wales from 1990 through 2007, were extracted from the national laboratory database (LabBase) and stored in a Microsoft Access (Microsoft Corp., Redmond, WA, USA) database.Cases were assigned to 10-year age groups and to geographic areas on the basis of laboratory location (northern, mid-country, southern).The season was assigned on the basis of the earliest available specimen date (spring, March-May; summer, June-August; autumn, September-November; winter, December-February).Data on cases of cryptosporidiosis and nontyphoidal salmonellosis for the same period were extracted and manipulated as above for comparative purposes.Denominator data for England and Wales for the same period were obtained from the Offi ce for National Statistics.Data were analyzed in Microsoft Excel 2003 and Stata version 10 (StataCorp, College Station, TX, USA).Estimates of incidence per 100,000 population were calculated throughout; relative risks (RR) and 95% confi dence intervals (CIs) were calculated as required.From 1990 through 2007 in England and Wales, 838,436 cases of Campylobacter infection were reported; patient age was available for 810,632 case-patients (96.7%).From 1990 through 1999, incidence increased in all age groups (Figure 1), but the increase was proportionate to increasing age (0-9 years of age RR 1.07 [95% CI 1.03-1.10];10-19 years RR 1.47 [95% CI 1.41-1.55];20-59 years RR 1.78 [95% CI 1.75-1.81];≥60 years RR 2.51 [95% CI 2.41-2.61]).From 2000 through 2004, incidence declined in all age groups.However, although the degree of decline was similar for those 0-9 years of age (RR 0.77 [95% CI 0.74-0.8]),10-19 years (RR 0.73 [95% CI 0.70-0.76]),and 20-59 years (RR 0.75 [95% CI 0.74-0.76]),for patients aged ≥60 years, the degree of decline was signifi cantly lower (RR 0.88 [95% CI 0.86-0.91];χ 2 p<0.001).Finally, although the incidence increased only moderately among those 10-19 years of age (RR 1.02 [95% CI 0.98-1.07])and 20-59 years (RR 1.04 [95% CI 1.03-1.06])from 2005 through 2007, greater increases were observed for those 0-9 years (RR 1.12 [95% CI 1.08-1.17])and those ≥60 years ).During the surveillance period, therefore, the incidence among patients >60 years of age, compared with the incidence among younger patients, increased markedly (RR 0.45 [95% CI 0.44-0.47] in 1990 to RR 1.17 [95% CI
No takes yet. Share an insight, caveat, or question.
Gillespie et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: